299180-15-7

Upstream product

• 74197-10-7 (+/-)-5-ethanamido-4,5,6,7-tetrahydroindazole 
• 30482-25-8 (1,4-dioxa-spiro[4.5]dec-8-yl)-methyl-amine 
• 299180-11-3 N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide 
• 69947-09-7 1,4-dioxaspiro<4.5>decane-8-carbonitrile 
• 30482-18-9 N-[(4-oxo-cyclohexyl)methyl]acetamide 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 299180-13-5 (+/-)-N-(4,5,6,7-tetrahydro-2H-indazol-5-ylmethyl)acetamide 

Relevant academic research and scientific papers

A general synthesis of novel conformationally restricted arginine side- chain mimetics

6-(Aminomethyl)-5,6,7,8-tetrahydro-2-quinazolinamine and 4,5,6,7- tetrahydro-2H-indazol-5-ylmethan-amine were synthesized as novel conformationally restricted arginine side-chain mimetics, designed for incorporation into trypsin-like serine protease inhibitors. (C) 2000 Elsevier Science Ltd.

Anticoagulant contrast media

The present invention provides novel anticoagulant contrast agents, which comprise an organic scaffolding moiety, an organic anticoagulant moiety, and an imaging moiety. The invention also provides anticoagulant contrast media and methods of visualizing internal structures utilizing the novel anticoagulant contrast agents and anticoagulant contrast media.